Next Article in Journal
Novel Fosfomycin Resistance Mechanism in Pseudomonas entomophila Due to Atypical Pho Regulon Control of GlpT
Previous Article in Journal
Isolation and Characterization of a Novel Jumbo Phage HPP-Temi Infecting Pseudomonas aeruginosa Pa9 and Increasing Host Sensitivity to Ciprofloxacin
 
 
Article
Peer-Review Record

Treatment of Carbapenem-Resistant Acinetobacter baumannii in Real Life (T-ACI): A Prospective Single-Center Observational Study

Antibiotics 2024, 13(11), 1007; https://doi.org/10.3390/antibiotics13111007
by Antonio Riccardo Buonomo 1,†, Riccardo Scotto 1,*,†, Nunzia Esposito 1, Giulio Viceconte 1, Nicola Schiano Moriello 1, Giulia Zumbo 1, Ilaria Vecchietti 1, Amedeo Lanzardo 1,2, Carmine Iacovazzo 3, Francesco Curcio 4, Emanuela Roscetto 5 and Ivan Gentile 1
Reviewer 1:
Reviewer 2: Anonymous
Antibiotics 2024, 13(11), 1007; https://doi.org/10.3390/antibiotics13111007
Submission received: 26 September 2024 / Revised: 21 October 2024 / Accepted: 23 October 2024 / Published: 25 October 2024

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

 

Dear authors, I have read your manuscript Treatment of Carbapenem-resistant Acinectobacter baumannii in real-life (T-ACI): a prospective single center observational study, and these are my comments and suggestions:

 

General: Write "Acinetobacter baumannii" in italics throughout the manuscript.

Title (Lines 1-4): What do you mean by "T-ACI"? I'm not sure it will be clear to the reader. The abbreviation is not used elsewhere in the manuscript.

Lines 28-29: Change to "Patients treated with an initial cefiderocol-based regimen showed a higher rate of ECS..." (it's either "a higher rate" or "higher rates").

Lines 31-32: Change to "No differences in OCS rates ...".

Lines 32-33: This sentence seems to be contradictory to what you said before. Please clarify.

Line 38: Change to "..., supporting the use of cefiderocol in clinical practice."

Lines 282-284: Change to "This difference was attributed to several factors, one of which was the very low life expectancy of the patients with CRAB infections included in the study."

Line 292: Is the abbreviation "ECS" referring to Effective Clinical Success or early clinical success as mentioned in line 24?

Lines 304-306: What kind of differences in clinical cure were these? Please specify.

Line 306: Change "emergent" to "emerged".

Comments on the Quality of English Language

I have given a few examples.

Author Response

Please find attached a point-by-point response.

Thank you

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Thisi a good work and well written although AI help

First, species names MUST be in italics

Discussion needs to be improved, particularly teh relatioship of the results obatined and other works worldwide, not only form Italy

Figure 1 has to be improved...not feasible to understand

Figure 2 might be submitted as supplementary material

Comments on the Quality of English Language

Minor revisions are needed

Author Response

Please find attached a point-by-point response.

Thank you

Author Response File: Author Response.pdf

Back to TopTop